Medinotec Inc. (MDNC) EBITDA (2022 - 2026)
Medinotec's (MDNC) quarterly EBITDA came in at $180872.0 in Q2 2026, down 34.81% YoY from $277457.0 in Q2 2025, and up 168.45% on a QoQ basis from -$264222.0 in Q1 2026.
Medinotec Inc. (MDNC) EBITDA (2022 - 2026) Analysis & Trends
Medinotec (MDNC) has 5 years of EBITDA data on file, last reported at $180872.0 in Q2 2026.
- Quarterly EBITDA fell 34.81% year-over-year to $180872.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $997927.0 (down 68.81% YoY) and the FY2026 annual result came in at $1.1 million, down 65.71% from the prior year.
- EBITDA advanced to $180872.0 in Q2 2026, from -$264222.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $2.0 million in Q1 2025 to a low of -$264222.0 in Q1 2026.
- A 5-year average of $257681.0 and a median of $213477.5 in 2024 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2023 — EBITDA soared 911.45% — and 2026, when it tumbled 113.49%.
- Tracing MDNC's EBITDA over 5 years: stood at $25499.0 in 2022, then soared by 911.45% to $257910.0 in 2023, then surged by 104.51% to $527451.0 in 2024, then grew by 4.79% to $552712.0 in 2025, then slumped by 67.28% to $180872.0 in 2026.
- The last three EBITDA figures came in at $180872.0 (Q2 2026), -$264222.0 (Q1 2026), and $552712.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 180,872.00 |
| Feb 28, 2026 | -264,222.00 |
| Nov 30, 2025 | 552,712.00 |
| Aug 31, 2025 | 528,565.00 |
| May 31, 2025 | 277,457.00 |
| Feb 28, 2025 | 1.96 Mn |
| Nov 30, 2024 | 527,451.00 |
| Aug 31, 2024 | 435,747.00 |
| May 31, 2024 | 269,168.00 |
| Feb 29, 2024 | 246,083.00 |
| Nov 30, 2023 | 257,910.00 |
| Aug 31, 2023 | 55,735.00 |
| May 31, 2023 | 40,850.00 |
| Feb 28, 2023 | -43,496.00 |
| Nov 30, 2022 | 25,499.00 |
| Aug 31, 2022 | -172,587.00 |
| May 31, 2022 | -48,001.00 |
| Feb 28, 2022 | -190,616.00 |